Clinical Research


Is clinical research right for you?


In clinical research, patients with specific conditions volunteer to try a new medication or medical device that is evaluated for effectiveness of treating their disease. These medications and devices are studied by scientists and healthcare specialists, as well as an institutional review board (IRB) to ensure the study is safe and ethical for patients.

At AOCC, we are growing our research department and actively enrolling our patients in studies.


Take a look at our current clinical research studies:

Enlight LN:This is an observational study for patients with Lupus Nephritis who have been started on Lupkynis (voclosporin) in the last 12 months.

COVID-19 Vaccine Study: This study evaluates the response of our patients to the COVID-19 vaccines.

COREVITAS Registry: This is part of an international registry of patients with rheumatic and autoimmune diseases that collects data and studies important correlates.

Novartis NEPTUNUS-1: A new investigational biologic for the treatment of active Sjogren’s syndrome. Click here to learn more: Two-arm Study to Access Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren’s Syndrome

Novartis AIN457: A trial investigating the use of Secukinumab in patients with a unilateral rotator cuff tendinopathy. Click here to learn more: Study of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff Tendinopathy

PRIMA: A blood test that will be used to determine how a patient with RA may respond to various biologics groups.

Alumis Lumus: A long term trial that is investigating the use of ESK-001, a TYK2 inhibitor, for patients with Systemic Lupus Erthematosus. Click here to learn more: Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus (LUMUS)

Ampel Relate: A single blood draw study that evaluate the use of the LuGENE test to evaluate disease activity in Systemic Lupus Erythematosus. Click here to learn more: Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) (ReLATE)


If you would like to learn more about enrolling in these trials, please call Audrey Droppelman at 704-631-3342 ext. 1170. You may also speak to your rheumatologist.